BCRX
Price
$9.81
Change
-$0.25 (-2.49%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
2.11B
77 days until earnings call
ETNB
Price
$8.19
Change
+$0.39 (+5.00%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
1.2B
85 days until earnings call
Ad is loading...

BCRX vs ETNB

Header iconBCRX vs ETNB Comparison
Open Charts BCRX vs ETNBBanner chart's image
BioCryst Pharmaceuticals
Price$9.81
Change-$0.25 (-2.49%)
Volume$158.9K
Capitalization2.11B
89bio
Price$8.19
Change+$0.39 (+5.00%)
Volume$22.51K
Capitalization1.2B
BCRX vs ETNB Comparison Chart
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCRX vs. ETNB commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a Hold and ETNB is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (BCRX: $9.85 vs. ETNB: $7.80)
Brand notoriety: BCRX: Notable vs. ETNB: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 176% vs. ETNB: 83%
Market capitalization -- BCRX: $2.11B vs. ETNB: $1.2B
BCRX [@Biotechnology] is valued at $2.11B. ETNB’s [@Biotechnology] market capitalization is $1.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $289.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileETNB’s FA Score has 1 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • ETNB’s FA Score: 1 green, 4 red.
According to our system of comparison, BCRX is a better buy in the long-term than ETNB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 6 TA indicator(s) are bullish while ETNB’s TA Score has 6 bullish TA indicator(s).

  • BCRX’s TA Score: 6 bullish, 4 bearish.
  • ETNB’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, BCRX is a better buy in the short-term than ETNB.

Price Growth

BCRX (@Biotechnology) experienced а -2.28% price change this week, while ETNB (@Biotechnology) price change was +0.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.30%. For the same industry, the average monthly price growth was +5.09%, and the average quarterly price growth was -6.29%.

Reported Earning Dates

BCRX is expected to report earnings on Jul 31, 2025.

ETNB is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-0.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($2.11B) has a higher market cap than ETNB($1.2B). BCRX YTD gains are higher at: 30.984 vs. ETNB (-0.256). BCRX has higher annual earnings (EBITDA): 47.6M vs. ETNB (-380.21M). ETNB has more cash in the bank: 639M vs. BCRX (295M). ETNB has less debt than BCRX: ETNB (37.6M) vs BCRX (795M). BCRX has higher revenues than ETNB: BCRX (503M) vs ETNB (0).
BCRXETNBBCRX / ETNB
Capitalization2.11B1.2B176%
EBITDA47.6M-380.21M-13%
Gain YTD30.984-0.256-12,115%
P/E RatioN/AN/A-
Revenue503M0-
Total Cash295M639M46%
Total Debt795M37.6M2,114%
FUNDAMENTALS RATINGS
BCRX: Fundamental Ratings
BCRX
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCRXETNB
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGLBX24.560.14
+0.57%
American Funds Global Insight R-2
GISTX34.49N/A
N/A
Goldman Sachs Technology Opps Inv
TIOTX15.59N/A
N/A
Nuveen International Opps Retire
VLSAX17.26N/A
N/A
Virtus KAR Long/Short Equity A
DBOAX23.43N/A
N/A
BNY Mellon Balanced Opportunity A

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
-3.82%
AKRO - ETNB
59%
Loosely correlated
+0.40%
RCKT - ETNB
57%
Loosely correlated
-5.50%
IDYA - ETNB
55%
Loosely correlated
-4.90%
COGT - ETNB
53%
Loosely correlated
-2.73%
NTLA - ETNB
52%
Loosely correlated
-2.69%
More